Tag: pharmacology

Posted on by

High-Yield Pediatric and Geriatric Prescribing Pearls

Prescribing gets riskiest at the two ends of life, and both are heavily tested for good reason. Children aren’t small adults, and older adults handle medications in ways that turn a routine dose into a hazard. A few pearls worth keeping front of mind:

Pediatrics. Weight-based dosing is the rule, and the arithmetic is where errors creep in — a missed decimal is a tenfold mistake. Some drug classes carry age-specific cautions (the classic teaching on certain antibiotics and tendons, aspirin and Reye syndrome, the developmental considerations around psychotropics). Formulations matter too: a dose that’s trivial to give as a liquid can be impossible as a tablet. And children’s faster clearance of some agents changes intervals in ways worth remembering.

Geriatrics. The theme is cumulative burden and narrowed margins. Renal and hepatic function decline, so standard doses can accumulate. Anticholinergic load stacks across seemingly unrelated medications and drives confusion and falls. Polypharmacy multiplies interactions, and tools like the Beers criteria exist precisely because certain drugs that are fine at 40 are risky at 80. The safe move is often “start low, go slow” — and periodically ask what can come off the list.

These distinctions reward review because they’re easy to blur when your daily practice skews toward one age group. The Pharmacology Review Course reinforces age-specific prescribing alongside the rest of the high-yield map — 12.5 hours of AAPA Category 1 CME, class by class, with teaching explanations. It’s $499.99 for 30 months, with the optional $100–$1,500 Amazon or Apple gift-card add-on.

Reinforce safe prescribing with CME →

Posted on by

Why Pharmacology Fades — and the Case for an Annual Review

Of everything a PA learns, pharmacology may have the shortest half-life. Anatomy stays put; a drug landscape does not. New agents arrive, indications expand, black-box warnings get added, and the guideline that put a medication first-line last year quietly moves it to second. Even a diligent clinician’s drug knowledge erodes simply because the ground keeps shifting — and because most practices lean on a narrow slice of the formulary, the rest goes quiet.

That’s the case for treating pharmacology as a recurring review rather than a one-time mastery. You wouldn’t expect a single course years ago to keep you current on anticoagulation reversal or the newest diabetes agents, any more than you’d expect last decade’s guidelines to hold. A periodic, structured pass keeps the whole map fresh, not just the corner you use daily.

An annual refresher also happens to be efficient CME. The Pharmacology Review Course delivers 12.5 hours of AAPA Category 1 credit in a focused, class-by-class format — enough to meaningfully update your knowledge without clearing your calendar, and it counts toward your requirement. Do it once a year and you keep both your prescribing and your CME log in good shape at the same time.

The clinicians who stay sharp on medications aren’t the ones with better memories; they’re the ones who revisit the material on a schedule. Build a yearly pharmacology review into your routine and you stop being surprised by a drug you “should” know. It’s $499.99 for 30 months, with the optional $100–$1,500 gift-card add-on.

Make pharmacology your annual refresher →

Posted on by

Anticoagulants, Antibiotics, Antihypertensives: A Category 1 CME Refresher

Three drug families sit at the center of everyday practice, and all three are moving targets. Get them right and a lot of medicine gets easier; get rusty and the second-guessing starts. They’re worth a periodic, deliberate refresh — not because you don’t know them, but because the details shift.

Anticoagulants have changed the most. DOACs have particular dosing by indication and renal function, specific reversal agents, and bridging decisions that trip people up. Keeping the current picture straight — when a DOAC is preferred, when warfarin still wins, how to manage a bleed — is high-stakes and high-yield. Antibiotics demand a working mental model of spectrum and resistance, plus the perennial questions around penicillin-cephalosporin cross-reactivity and stewardship. Antihypertensives reward knowing first-line choices by comorbidity (the diabetic, the patient with heart failure, the pregnant patient) and the contraindications that turn a reasonable choice into a harmful one.

A refresher works best when it puts these side by side and tests you on the distinctions, rather than leaving you to notice a gap only when a patient is in front of you. The Pharmacology Review Course does that across these families and the rest of the high-yield map: 12.5 hours of AAPA Category 1 CME, organized by class, with teaching explanations that reinforce the why. You come out sharper on the medications you reach for most — and you log documented credit doing it. It’s $499.99 for 30 months, with the optional $100–$1,500 Amazon or Apple gift-card add-on.

Refresh your prescribing with 12.5 hours of CME →

Posted on by

Pharmacology + PANRE Together: The Highest-Yield Study Combo for Recert

If you’re recertifying and want the most score improvement per hour studied, the data-backed answer is almost always the same: shore up pharmacology. It threads through every organ system on the blueprint, it’s the content most likely to have drifted since you last studied it, and it’s dense enough that a focused pass produces outsized gains. That’s why pairing the two courses works so well.

The PANRE Review Course gives you the breadth — 1,200 questions across the full blueprint, 5 mock exams, and 100 hours of AAPA Category 1 CME. The Pharmacology Review Course gives you the depth exactly where it pays off most — 12.5 focused hours of AAPA Category 1 CME organized class-by-class. Run the pharmacology review first or alongside your board prep, and the drug questions scattered throughout the PANRE bank stop being the ones you dread.

The CME math is worth noting too. Together the two courses total 112.5 hours of AAPA Category 1 credit — comfortably covering a recertification cycle’s requirement while doing the actual work of getting you exam-ready. And both carry the optional Amazon or Apple gift-card add-on ($100–$1,500), so if you have an employer allowance, one combined purchase can cover your prep, your CME, and return real value to you.

There’s no trick here — just leverage. Pharmacology is the weak point most PAs share, board exams test it heavily, and fixing it lifts everything else. Do that alongside a full blueprint review and you walk in genuinely prepared, not just credentialed. Each course is $499.99 for 30 months of access.

Bundle your PANRE and Pharmacology prep →

Posted on by

The 10 Drug Classes PAs Miss Most — and How to Lock Them Down

Certain drug classes show up again and again on the list of things PAs wish they knew cold. They’re high-stakes, detail-dense, and constantly evolving — which is exactly why they’re easy to miss under exam pressure and easy to get rusty on in practice. A quick tour of the usual suspects:

  • Anticoagulants & antiplatelets — DOAC dosing, reversal agents, and bridging still cause the most hesitation.
  • Antibiotics — spectrum, resistance patterns, and the allergy cross-reactivity questions everyone second-guesses.
  • Insulins & antidiabetics — onset/peak profiles and the newer GLP-1 and SGLT2 agents.
  • Antihypertensives — first-line choices by comorbidity and the contraindication traps.
  • Psychotropics — SSRIs/SNRIs, serotonin syndrome, and monitoring.
  • Anticonvulsants — interactions and level monitoring.
  • Steroids & immunosuppressants — tapering and adverse-effect profiles.
  • Opioids & pain management — equivalence and safe prescribing.
  • Anticholinergics — the cumulative-burden questions, especially in older adults.
  • Cardiac agents — digoxin, antiarrhythmics, and their narrow margins.

The fix isn’t cramming — it’s a structured pass that puts these classes side by side so the distinctions stick. The Pharmacology Review Course is organized exactly that way: 12 hours of AAPA Category 1 CME, built class-by-class around the material most likely to be tested and prescribed. You reinforce the whole map, drill the classes you know are soft, and earn documented credit while you do it. It’s $499.99 for 30 months, with the same optional $100–$1,500 Amazon or Apple gift-card add-on.

Sharpen these classes with the Pharmacology Review Course →